ROCK Research Group Wins IMPACT Award for Knee Osteochondritis Breakthroughs
Event summary
- The ROCK Research Study Group received the 2026 IMPACT Award for 15 years of work on knee osteochondritis dissecans (OCD).
- ROCK has enrolled over 1,900 patients across 25 academic centers since 2014.
- Developed a reliable six-category arthroscopic classification system and prediction algorithms for nonoperative treatment success.
- Conducted randomized controlled trials comparing OCD drilling techniques.
The big picture
The IMPACT Award highlights the strategic importance of evidence-based research in orthopedic care, particularly for conditions like OCD that can lead to long-term joint damage. ROCK's work represents a significant advancement in standardized classification and data-driven treatment approaches, addressing critical gaps identified in AAOS's 2010 Clinical Practice Guideline. The consortium's international collaboration and multidisciplinary approach position it as a leader in musculoskeletal research.
What we're watching
- AI Integration
- How ROCK's AI-driven platform will affect diagnostic precision and treatment personalization for knee OCD.
- Biological Therapies
- Whether growth factors, stem cell therapies, and other biologics can enhance healing beyond current surgical techniques.
- Research Expansion
- The pace at which ROCK's database grows and improves its prediction algorithms for nonoperative treatment success.
Related topics